Nur (NURI) AI Stock Analysis

Top Page

Nur

(TASE:NURI)

Select Model

Rating:44Neutral

Price Target:ILA 595.00▼(-3.03% Downside)

Action:reiterated

Date:08/26/26

The score is driven primarily by weak financial performance—large ongoing losses and significant cash burn outweigh the healthier leverage position. Technicals are also a headwind given the strong downtrend, with only an oversold RSI offering limited near-term support. Valuation signals are constrained because the company is loss-making and offers no dividend yield.

Positive Factors

Revenue reboundThe sharp year-over-year revenue rebound shows that Nur has achieved measurable top-line expansion, even from a small base. Continued growth would improve operating leverage and provide a larger platform for its banking and cryptocurrency services to develop over the next several quarters.

Negative Factors

Persistent lossesLarge net losses and negative gross profit indicate that Nur has not yet demonstrated an economically viable operating model. Continued losses can consume its equity base, constrain investment in the platform, and make a durable path to break-even dependent on substantial improvement.

Nur (NURI) vs. iShares MSCI Israel ETF (EIS)

Market Cap: ILS 31.81M
Dividend Yield: ―
Average Volume (3M): 7,209
Price to Earnings (P/E): -4.2
Beta (1Y): 0.81
Revenue Growth: 104.30%
EPS Growth: 2.80%
Country: Israel
Employees: 18
Sector: General
Sector Strength: 55
Industry: Industrial - Specialties

Nur Business Overview & Revenue Model

Company Description

Nur Ink Innovations Ltd engages in the design, development, and production of water-based pigmented inks for digital inkjet printing applications in Israel. It offers Digital Sol-Gel, a water-based pigment ink for digital printing for direct-to-garme...

Nur Financial Statement Overview

Summary

Despite strong percentage revenue growth off a very small base, profitability is deeply negative with negative gross profit and large net losses. Cash flow remains a major weakness due to persistent operating and free cash flow burn, implying continued reliance on external funding. The balance sheet is a relative bright spot with low debt-to-equity and positive equity, but returns on equity are very poor due to ongoing losses.

Income Statement

9Very Negative

Balance Sheet

54Neutral

Cash Flow

12Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	380.00K	327.00K	253.00K	0	0	0
Gross Profit	-3.33M	-3.06M	-2.69M	-1.72M	-84	-137
EBITDA	-8.37M	-6.99M	-7.56M	-11.35K	-10.18M	-7.07M
Net Income	-11.24M	-9.42M	-9.66M	-12.86M	-11.61M	-7.78M
Balance Sheet
Total Assets	20.65M	22.74M	18.39M	21.83K	33.29K	41.07K
Cash, Cash Equivalents and Short-Term Investments	699.00K	4.14M	5.63M	10.44K	21.33K	32.90K
Total Debt	1.89M	2.17M	2.70M	2,698	3,122	3,507
Total Liabilities	6.05M	5.84M	5.56M	5,758	5,481	5,276
Stockholders Equity	14.60M	16.90M	12.83M	16.08K	27.80K	35.80K
Cash Flow
Free Cash Flow	-8.99M	-7.85M	-7.13M	-10.17K	-8,094	-9,121
Operating Cash Flow	-8.56M	-7.50M	-6.61M	-9,316	-6,273	-6,341
Investing Cash Flow	-4.86M	-155.00K	418.00K	485	-14.40K	-3,309
Financing Cash Flow	13.12M	10.04M	5.22M	-447	-385	42.39K

Nur Technical Analysis

Technical Analysis SentimentNegative

Last Price613.60

Price Trends

50DMA682.52Negative

100DMA757.47Negative

200DMA932.93Negative

Market Momentum

MACD-19.13Negative

RSI30.86Neutral

STOCH95.90Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NURI, the sentiment is Negative. The current price of 613.60 is below the 20-day moving average (MA) of 625.06, below the 50-day MA of 682.52, and below the 200-day MA of 932.93, indicating a bearish trend. The MACD of -19.13 indicates Negative momentum. The RSI at 30.86 is Neutral, neither overbought nor oversold. The STOCH value of 95.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:NURI.

Nur Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IL:NURI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IL:NXSN	70Outperform	ILS 18.27B	35.11	―	0.85%	62.12%	46.67%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IL:SCDX	46Neutral	ILS 31.59M	-1.95	―	―	-38.60%	-428.31%
IL:NURI	44Neutral	ILS 53.77M	-4.23	―	―	104.30%	2.80%
IL:PHTM	41Neutral	ILS 38.42M	-3.79	―	―	12.14%	43.83%
IL:MSVT	40Underperform	ILS 23.68M	-0.38	―	―	-40.18%	67.38%

* General Sector Average

Performance Comparison

IL:NURI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IL:NURI	NUR INK INNOVATIONS LTD	613.60	-593.40	-49.16%
IL:VISN	Vision Sigma Ltd	3843.00	-2015.00	-34.40%
IL:SCDX	Scodix Ltd.	91.70	-166.45	-64.48%
IL:PHTM	Photomyne Ltd	1427.00	-1065.00	-42.74%
IL:MSVT	MASSIVIT 3D PRINTING TECHNOLOGIES LTD	34.30	-51.10	-59.84%
IL:NXSN	NextVison Stabilized Systems, Ltd.	19720.00	4620.00	30.60%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 26, 2026

Nur AI Stock Analysis